Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, FTC report on abbreviat...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2003.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, FTC report on abbreviated new drug applications, FDA rule change regarding requirements for listing pharmaceutical patents in the Orange Book, and various legislative proposals in the 108th Congress to amend the Hatch-Waxman Act. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |